BNP Paribas Financial Markets
KZIA

BNP Paribas Financial Markets’s Kazia Therapeutics KZIA Stock Holding History

BNP Paribas Financial Markets’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
30,090
+29,009
+2,684% +$353K ﹤0.01% 3849
2026
Q1 		$8.04K Buy
+1,081
New +$7.53K ﹤0.01% 5254
2024
Q3 		– Sell
-1,271
Closed -$14.5K – 4194
2024
Q2 		$14.5K Buy
1,271
+299
+31% +$4.45K ﹤0.01% 3682
2024
Q1 		$15.1K Buy
972
+718
+283% +$10.8K ﹤0.01% 3665
2023
Q4 		$5.58K Buy
254
+84
+49% +$2.46K ﹤0.01% 3742
2023
Q3 		$8.46K Buy
170
+104
+158% +$5.08K ﹤0.01% 3637
2023
Q2 		$3.76K Buy
+66
New +$4.16K ﹤0.01% 3690

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets's KZIA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Kazia Therapeutics (KZIA) stake by 2,684% in Q2 2026, buying an estimated $353K and bringing the position to 30,090 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #3849.

BNP Paribas Financial Markets first reported a position in KZIA in Q2 2023 and has held it in 7 quarters since. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • BNP Paribas Financial Markets held 30,090 shares of Kazia Therapeutics worth $424K as of Q2 2026.
  • BNP Paribas Financial Markets bought 29,009 Kazia Therapeutics shares in Q2 2026, an estimated $353K.
  • Kazia Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3849 holding.
  • BNP Paribas Financial Markets first reported a position in Kazia Therapeutics in Q2 2023 and has held it in 7 quarters since.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.